HomeELAN • NYSE
add
Elanco Animal Health Inc
Previous close
$13.31
Day range
$12.79 - $13.22
Year range
$7.88 - $16.88
Market cap
6.43B USD
Avg Volume
3.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.04B | 5.08% |
Operating expense | 504.00M | -0.40% |
Net income | -141.00M | -161.11% |
Net profit margin | -13.62 | -148.54% |
Earnings per share | 0.08 | -57.89% |
EBITDA | 134.00M | 0.00% |
Effective tax rate | -11.02% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 352.00M | 2.03% |
Total assets | 14.36B | -7.29% |
Total liabilities | 8.14B | -0.77% |
Total equity | 6.22B | — |
Shares outstanding | 492.97M | — |
Price to book | 1.05 | — |
Return on assets | 0.30% | — |
Return on capital | 0.35% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -141.00M | -161.11% |
Cash from operations | 157.00M | 1,107.69% |
Cash from investing | -35.00M | 53.95% |
Cash from financing | -139.00M | -65.48% |
Net change in cash | -17.00M | 85.22% |
Free cash flow | 199.75M | 311.66% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,550